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Abstract: The estrogen receptor protein (ER) can bind a vast number of organic pollutants 
widely spread in the environment and collectively known as Endocrine Disrupting 
Chemicals, EDCs. Its broad selectivity makes it an ideal bio-recognition element for the 
detection of EDCs. Here we describe the strategy and rationale for the design of ER based 
biosensors and assays that generate a signal in the presence of EDCs. The opportunity to use 
either natural or rationally modified ER molecules is discussed. The latter approach was 
successfully applied in the EU-FP7 project RADAR, with the aim to develop a novel 
biosensor for the detection of organic pollutants both in the environment and in commercial 
water products. 
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1. Introduction 
Endocrine Disrupting Chemicals (EDCs) are a class of organic pollutants with an ever increasing 
presence in the environment. Sources of EDCs are ubiquitous in both industrial and consumer context, 
including industrial and residential (plastic products, pharmaceuticals, detergents) as well as agricultural 
waste. There is an increased demand for the detection and monitoring of these pollutants in the 
environment both at the consumer and legislative level. Hundreds of new EDCs with little or no 
toxicological characterization are released each year. Furthermore, other molecules that are not toxic per 
se can be degraded in the environment and transformed into EDC pollutants.  
Given the sheer number of existing, new and unknown EDCs, designing chemical assays or detection 
strategies for each individual compound is not obvious. Studying the biological action of EDC 
compounds, however, offers a chance to develop assays and sensors capable of detecting the presence 
even of unknown, potentially toxic chemicals. 
Vertebrates utilize the estrogen receptor signaling pathway to regulate gene expression in the presence 
of steroidal hormones. This pathway plays a key role in development and maintenance of normal sexual 
and reproductive functions and has also effect on the cardiovascular, musculoskeletal, immune and 
central nervous systems [1]. 
Estrogen Receptor (ER) is a protein that, in the presence of hormones, can regulate the above 
mentioned signaling pathways. During a normal response, 17β-estradiol binds to ER and activates the 
signal transduction resulting in regulation of gene expression [2]. Besides its natural ligands, ER can 
bind several other chemical compounds [3,4]; once bound, these can inhibit or abnormally stimulate the 
ER activity, disrupting its effects (Figure 1). Every molecule that can bind to ER and interfere with its 
activity is defined as an Endocrine Disrupting Chemical (EDC). EDCs have been linked to several 
diseases such as cancer, malfunctions of the reproductive and immune system [5,6] and sex change in 
fish and amphibians [7–13].  
Given the above, ER protein itself can be a tool for the detection of such organic pollutants.  
An assay or sensor device that can provide a signal if an organic molecule binds to ER can, in fact,  
be used to detect the presence of EDCs. No a priori knowledge on the compounds to be investigated is 
needed: any molecule that can bind to ER and give a signal in the assay or sensor has the potential to 
bind ER in the body, as well, exerting a toxic action. 
The concept of detecting a signal when a target binds to bio-recognition proteins has widespread uses 
with antibodies, either via biochemical (e.g., ELISA) or biophysical assays. However, using ER instead 
of antibodies as a bio-recognition element for EDCs has an important advantage. Antibodies are highly 
sensitive but are usually also highly specific (Figure 2); each antibody can only recognize a small number 
of similar molecules. Having different antibodies against the thousands of known EDC pollutants would 
be a daunting task, and it would be almost impossible to have antibodies against unknown EDC 
compounds. By contrast, any molecule that binds to ER protein is by definition a potentially toxic EDC. 
Detection of a signal in an ER based assay or sensor would thus alert to the presence of dangerous 
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organic pollutants, even if these pollutants are initially unknown and not specifically searched for. The 
obvious disadvantage is that such assays would not be able to identify a specific pollutant; therefore, 
further analysis by traditional (and slower) methods would be required. However, alerting to the presence 
in the environment of any potential pollutant is certainly valuable. An ER-based sensor or assay would 
be used in routine controls and/or early warning systems. Detection of a potential threat by this method 
would then warrant further investigation. 
 
Figure 1. Estrogen Receptor protein (ER) regulate gene expression after binding hormones, 
schematically shown on the left. Endocrine Disrupting Chemicals (right) bind ER and 
provoke an abnormal physiological response, either inhibiting or untimely activating the 
normal ER functions. Many diseases are associated with Endocrine Disrupting Chemical 
(EDCs). 
2. Producing ER Protein as a Bio-Recognition Element 
The Estrogen Receptor protein can be used as a bio-recognition element for the detection of organic 
pollutants. Given that all vertebrates have ERs, the first step for the design of a bio-sensor is choosing 
which species to derive the ER from. If the main focus of the bio-sensor is to detect compounds 
potentially toxic for humans, it would then be appropriate to use human ER as a bio-recognition element. 
Anything that binds to the biosensor, in fact, would also have the potential to bind to ER in the human 
body. Conversely, monitoring the presence of pollutants in water might suggest the use of ER from 
aquatic species. The choice is less critical than it might appear. Comparison of the protein sequence of 
ER from several species indicates that two regions of the protein are highly conserved: the DNA binding 
domain and the ligand binding domain [14–16] (Figure 3).  
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Figure 2. Schematic representation of a biosensor utilizing either antibodies (left) or  
ER protein (right) as bio-recognition elements. Antibodies, shown in red, are highly sensitive 
and usually highly specific. Each antibody would bind single EDCs and would not be able 
to detect the presence of others. By contrast, ER proteins bind any EDC.  
An ER based sensor would be able to detect the presence of any EDCs, even initially 
unknown compounds. 
 
Figure 3. Sequence alignment of ER protein from different species. Blue color indicates 
conserved residues. The DNA binding and ligand binding domains are highlighted. 
The former domain is required to achieve regulation of gene expression whereas the latter is necessary 
and sufficient to bind estradiol and other ligands. Only the ligand binding domain, therefore, is strictly 
required as a bio-recognition element for EDCs. Production of the isolated ligand binding domain rather 
than the full ER protein may have practical advantages. For instance, smaller globular protein domains 
are often easier to produce in bacterial systems (see below) and are more stable over time. On the other 
hand, each protein is different and general rules are difficult to draw. Production of full, multi-domain 
proteins might be better suited for some application. In the EU-FP7 funded RADAR project we 
discovered that the isolated ER ligand binding domain is easy to produce, sufficiently stable over time 
and capable of detecting EDCs [17,18]. If the ER ligand binding domain is used as  
bio-recognition element, choosing which species to derive the protein from has very small impact: the 
domain is so highly conserved, especially the region responsible for binding EDCs (called ligand binding 
pocket), that any given protein sequence is suitable. 
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Having chosen the exact ER protein sequence to use, the subsequent step in the design of an ER based 
biosensor or assay is the actual production of sufficient quantities of the protein. “Sufficient” for 
laboratory testing usually means milligrams of purified and active protein. Industrial production would 
require apt scale up of the manufacturing protocols. Isolating and purifying ER protein from animals 
that naturally produce it would obviously be an impractical option. A better alternative is to produce 
recombinant ER protein from suitable expression systems, namely bacterial, eukaryotic or mammalian 
cell lines. The latter hosts yield proteins more similar to those present in animals. In particular, post-
translational protein modifications such as glycosylation are not obtainable from production in standard 
bacterial systems. However, bacterial expression (typically in E. coli) is much cheaper, usually yields 
higher quantities of purified material and has less complicated regulatory requirements. For these 
reasons, bacterial systems are often preferred, provided that the produced protein is functional. 
Purification of the ER protein expressed in the system of choice is not particularly challenging and can 
be conducted according to standard techniques, often involving an affinity purification chromatography 
step followed by a size exclusion chromatography step [18]. 
3. Modify the Natural ER Protein 
The ligand binding domain of the natural (wild type, wt) ER protein can be produced and used as a 
bio-recognition element capable of generating a signal if EDC pollutants are present in an analyzed 
sample. However, modification of the natural protein might be desirable for specific purposes.  
For instance, if ER needs to be linked to a solid support for an assay or biosensor, introduction of a 
chemical tag in the recombinant ER (e.g., an His-tag), might facilitate the task as well as aid in protein 
purification. In other cases the recombinant ER protein might not be stable for a sufficiently long amount 
of time. Improving shelf life can often be achieved by changing storage conditions  
(buffer, formulation, etc.). Other times, modification of the amino acid sequence of the protein might be 
necessary. Although a detailed explanation of this approach goes beyond the scope of this manuscript, 
one example might help to illustrate the process. Purified proteins tend to aggregate over time, leading 
to loss of activity. Aggregation is often initiated by the presence of hydrophobic residues (patches) on 
the protein surface, which attract similar patches on other molecules. Replacing these hydrophobic 
residues with hydrophilic amino acids in the recombinant protein has the potential to decrease 
aggregation and increase stability.  
Finally, the ER residues responsible for interaction with EDCs might be modified to increase the 
binding affinity, and thus improve sensitivity, for all or selected classes of pollutants. Achieving this 
result is not trivial but can be attempted with two general strategies. One option is to randomly mutate 
the ER protein sequence, generate as vast a library of different mutants as possible and then select the 
mutants with desired binding properties (e.g., higher affinity for a given chemical). The generation of 
random protein sequences can be achieved by synthetic gene libraries [19] or by yeast- or phage-display 
technologies [20–22].  
A second approach involves the rational modification of specific residues that play important role in 
the interaction of ER with EDCs. These are best identified by structural analysis of the atomic, three-
dimensional structure of ER protein in complex with various EDCs. Structural information allows, in 
fact, to visualize the chemical interactions responsible for EDC binding. Critical ER residues forming 
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intermolecular contacts such as hydrogen bonds or aromatic interactions can be identified. Mutations in 
these positions can then be introduced to either disrupt intermolecular interactions and abrogate binding 
or, conversely, to favor binding of selected EDCs. Experimentally determined X-ray structures of ER 
protein bound to several different EDC compounds are available [4,23,24]. Binding of other EDCs of 
interest can also be simulated by computational docking algorithms [18]. The advantage is that 
computational simulations are usually fast and inexpensive. The disadvantage is that computational 
solutions often lack precision and accuracy. As an example, structural analysis based on both X-ray and 
computational data reveals that most EDCs bind to a hydrophobic binding pocket in the ER ligand 
binding domain. Since many EDCs have aromatic chemical moieties, increasing the aromatic content of 
the ER binding pocket might strengthen ER/EDC binding (and thus affinity) through the formation of 
energetically favorable intermolecular aromatic stacking interactions. Indeed, simulations suggest that 
mutating residue M421, in the ER ligand binding pocket, to F421 or Y421 might increase the affinity of 
ER to molecules such as estradiol and bisphenol (Figure 4). Furthermore, sequence analysis of ER 
proteins shows that residue M421 is mutated to F421 in some aquatic species. Since ERs with F421 exist 
in nature and are obviously stable and functional, it is likely that introducing a M421F mutation in any 
given ER sequence would not cause disruption of the ER structure and consequent loss of activity. 
Indeed, we were recently able to show that a M421F ER mutant can bind estradiol with approximately 
10 fold higher affinity and bisphenol with 4 fold higher affinity [18], proving that the above described 
strategy is viable. 
4. Conclusions 
ER protein can be used as a bio-recognition element for the detection of a class of organic pollutants, 
collectively known as EDCs, that are toxic, widespread in the environment and whose monitoring and 
detection is increasingly required by legislation and consumer pressure alike. The advantages of using 
ER instead of antibody-based or chemical analysis is that any compound that exerts toxicity by binding 
to natural ER in animals will also bind to a recombinant ER protein in a biochemical assay or sensor. 
Even unknown and yet uncharacterized compounds can be detected, whereas they would fail to be 
recognized by antibodies or other specific assays. The main disadvantage of the broad selectivity linked to a 
recombinant ER bio-recognition element is that, although the presence of pollutants in a sample can be 
detected, such pollutants cannot be identified. Nonetheless, one can envisage the use of an early warning, 
ER based detection system that could signal the presence of potentially toxic EDCs. A positive sample 
would then be subjected to more expensive and time consuming chemical investigation with the purpose 
of identifying the organic pollutants. 
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Figure 4. Part of the ER ligand binding domain is shown in grey cartoon, with the M421F 
mutation (see main text) shown in red. Computational simulations predict this ER mutant to have 
an increased affinity for estradiol (green) and bisphenol (blue). The two molecules cannot bind 
simultaneously but are shown superimposed in the ligand binding pocket for clarity. 
In this manuscript we described the strategy and considerations that can lead to the design of ER 
based bio-recognition elements. These are applicable to other classes of natural protein receptors or 
enzyme capable of binding to, and thus detecting, different molecules. We recently used this strategy in 
the EU-FP7 research project RADAR, producing recombinant ER that could detect estradiol, an EDC, 
in a chromatography-mass spectroscopy assay more sensitive and convenient than currently available 
methods [17]. We were also able to generate rationally designed ER mutants with increased affinity for 
several EDCs [18] , leading to increased sensitivity in an ER based fluorescent assay.  
A label free, SPR based biophysical assay for the detection of selected EDCs has also been hinted to [25], 
although no finished biosensor has so far been produced. 
The use of recombinant proteins as bio-recognition elements in biochemical and biophysical assays 
has steadily moved forward in recent years, becoming more affordable thanks to robotics, 
miniaturization and microfluidics. Recent advances in structural biology, computational simulations 
protein engineering allow us to move one step further: the natural proteins can be altered to ameliorate 
their properties. Protein mutations can positively affect the binding affinity for ligands (linked to assay 
sensitivity), selectivity and specificity or protein stability (particularly important for on-field biosensors). 
Mutating a protein to achieve a desired outcome remains a difficult endeavor; however, improved 
understanding of the principles of protein structure and protein interactions has greatly increased the 
success rate for protein engineering. Success is far from being guaranteed, but goals that were almost 
impossible a few years ago are nowadays worth pursuing. 
Rational modification of natural protein receptors is an option certainly worth considering when 
planning the design of new bio-sensors. 
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